CARCINOMA

This program provides access to the experimental drug taletrectinib for adults with advanced ROS1-positive lung cancer who have run out of approved treatment options and cannot join regular clinical trials. The drug aims to control cancer growth in patients who have already tried…

This study is testing whether adding a second drug, savolitinib, to a standard lung cancer drug, osimertinib, can help control cancer that has started growing again. It is for adults with a specific type of advanced non-small cell lung cancer whose disease progressed after initia…

This early-stage study is testing whether delivering one chemotherapy drug directly into the abdomen, while giving two others by mouth and vein, is safe and tolerable for people with advanced abdominal cancer from colorectal or appendix tumors. The treatment is given after surger…

This early-stage study is testing a new type of personalized cell therapy for children and young adults whose solid tumors have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cance…

This study is testing a new targeted drug called savolitinib for people with an advanced form of kidney cancer called MET-driven papillary renal cell carcinoma (PRCC). It compares savolitinib directly against sunitinib, a standard treatment, to see which is better at controlling …

This early-phase study is testing the safety and feasibility of a new treatment called CAR T-cell therapy for children and young adults whose solid tumors have come back or not responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to be…

This study is testing a new computer program designed to help doctors during colonoscopies. The software analyzes images from the procedure to automatically find growths and tell doctors how likely they are to be pre-cancerous (adenoma) or non-cancerous (non-adenoma). Researchers…

This study compares two standard treatments for early-stage throat cancer to see which better preserves patients' quality of life, especially their ability to swallow. It randomly assigns 138 patients to receive either minimally invasive robotic surgery or targeted radiation ther…

This study aims to understand how radiation therapy for cancer affects the body by collecting blood and urine samples from patients. Researchers will analyze these samples to see changes in genes, cells, and hormones. The goal is to gather knowledge, not to provide a new treatmen…